In Emilia-Romagna, the observed increase in insulin prescriptions during pregnancy between 2004 and 2010 was 232%.
Notes on verification
Confirmed by EpiCentro (ISS), a reliable public health source, citing a peer-reviewed PLOS One study (Charlton et al. 2016). The specific percentage figures were not directly verifiable in the retrievable primary source text, but the overall pattern (Emilia-Romagna's smaller increase relative to Tuscany, same study/timeframe) was corroborated. [tier=silver indep_score=1.0 clusters=2 claim_tier=notable | framework convergence=single on EUROmediCAT common protocol and seven regional prescription databases (including Emilia Romagna and Tuscany) (upstreams: EUROmediCAT project, Charlton et al. 2016 PLOS One study 'Prescribing of Antidiabetic Medicines before, during and after Pregnancy: A Study in Seven European Regions') — publishers independent, evidence may not be | kind=attributed eligibility=high]
Sources
- Farmacoepidemiologia documentazione in Europa (seed:health_and_medicine)
- https://pmc.ncbi.nlm.nih.gov/articles/PMC4871589/ (corroboration)
- https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0155737 (corroboration)
- https://pubmed.ncbi.nlm.nih.gov/27192491 (corroboration)